Butyric Acid Modulates Gut Microbiota to Alleviate Inflammation and Secondary Bone Loss in Ankylosing Spondylitis
<b>Background:</b> Ankylosing spondylitis (AS) is a chronic inflammatory and autoimmune disease that primarily affects the sacroiliac joints and axial skeleton. While the exact pathogenetic mechanism of AS remains unclear, previous reports have highlighted the involvement of genetic fact...
Saved in:
| Main Authors: | Ke You, Lianjun Yang, Zhihai Su, Jun Shen, Xinyang Fan, Yuanqing Guo, Zhen Yuan, Hai Lu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/1/9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Limosilactobacillus reuteri prevents progression of ankylosing spondylitis in mice by restoring gut microbiota-metabolism homeostasis
by: Lianjun Yang, et al.
Published: (2025-07-01) -
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01) -
Musculoskeletal losses in patients with ankylosing spondylitis
by: T. A. Raskina, et al.
Published: (2019-10-01) -
OSTEOPOROSIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Elena Efimovna Gubar, et al.
Published: (2013-12-01) -
EXPERIENCE WITH RITUXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: Mikhail Sergeyevich Protopopov, et al.
Published: (2013-02-01)